Search
![Disc Medicine's CEO reviews recent EHA data, including learnings about clinical endpoints from the company's lead GlyT1 program](https://static.wixstatic.com/media/08e71b_dfca0002c5a84a9b941f17b9645507d8~mv2.png/v1/fill/w_326,h_245,fp_0.50_0.50,q_95,enc_auto/08e71b_dfca0002c5a84a9b941f17b9645507d8~mv2.png)
- 6 days ago
Disc Medicine's CEO reviews recent EHA data, including learnings about clinical endpoints from the company's lead GlyT1 program
John Quisel describes how bitopertin aims to reduce PPIX, a photosensitiser that makes it painful for patients when exposed to light....